Uncovering evolutionarily remote and highly potent antimicrobial peptides with protein language models.

IF 26.3 1区 医学 Q1 ENGINEERING, BIOMEDICAL
Qinze Yu,Hongbin Liu,Haimei Shi,Yerzhan Abdrakhmanov,Junbo Shen,Chunhe Zhang,Zhihang Dong,Licheng Zong,Longlong Si,Lei Dai,Yu Li
{"title":"Uncovering evolutionarily remote and highly potent antimicrobial peptides with protein language models.","authors":"Qinze Yu,Hongbin Liu,Haimei Shi,Yerzhan Abdrakhmanov,Junbo Shen,Chunhe Zhang,Zhihang Dong,Licheng Zong,Longlong Si,Lei Dai,Yu Li","doi":"10.1038/s41551-026-01630-w","DOIUrl":null,"url":null,"abstract":"Identifying evolutionarily remote antimicrobial peptides (AMPs) is crucial for discovering underexplored clinical candidates to combat antibiotic resistance. Existing experimental and computational methods are limited by their reliance on sequence identity to known AMPs, missing distant homologues. Here we introduce HMD-AMP, a protein language model-based approach for AMP discovery. HMD-AMP outperforms previous methods in identifying evolutionarily distant AMPs and enables the discovery of unknown and highly potent AMPs from metagenomic data. Applied to host and gut microorganism genomes of nine mammals, HMD-AMP revealed over 37 million predicted AMPs. Of 91 high-confidence sequences experimentally validated, 74 showed strong antibacterial activity and 48 were evolutionarily remote from known AMPs. Four of these AMPs exhibited broad-spectrum antibacterial activity at low effective concentrations and showed low toxicity, with the most potent peptide demonstrating therapeutic efficacy in a mouse model of peritoneal Escherichia coli infection. This study introduces an effective strategy to uncover AMPs.","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"268 1","pages":""},"PeriodicalIF":26.3000,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41551-026-01630-w","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Identifying evolutionarily remote antimicrobial peptides (AMPs) is crucial for discovering underexplored clinical candidates to combat antibiotic resistance. Existing experimental and computational methods are limited by their reliance on sequence identity to known AMPs, missing distant homologues. Here we introduce HMD-AMP, a protein language model-based approach for AMP discovery. HMD-AMP outperforms previous methods in identifying evolutionarily distant AMPs and enables the discovery of unknown and highly potent AMPs from metagenomic data. Applied to host and gut microorganism genomes of nine mammals, HMD-AMP revealed over 37 million predicted AMPs. Of 91 high-confidence sequences experimentally validated, 74 showed strong antibacterial activity and 48 were evolutionarily remote from known AMPs. Four of these AMPs exhibited broad-spectrum antibacterial activity at low effective concentrations and showed low toxicity, with the most potent peptide demonstrating therapeutic efficacy in a mouse model of peritoneal Escherichia coli infection. This study introduces an effective strategy to uncover AMPs.
用蛋白质语言模型揭示进化上遥远和高效的抗菌肽。
鉴定进化远程抗菌肽(amp)对于发现未开发的临床候选物以对抗抗生素耐药性至关重要。现有的实验和计算方法受限于它们依赖于已知amp的序列同一性,而缺少遥远的同源物。在这里,我们介绍HMD-AMP,一种基于蛋白质语言模型的AMP发现方法。HMD-AMP在识别进化上遥远的amp方面优于以前的方法,并能够从宏基因组数据中发现未知和高效的amp。将HMD-AMP应用于9种哺乳动物的宿主和肠道微生物基因组,发现超过3700万个预测amp。在实验验证的91个高置信度序列中,74个显示出较强的抗菌活性,48个在进化上与已知的AMPs距离较远。其中四种抗菌肽在低有效浓度下表现出广谱抗菌活性,并显示出低毒性,其中最有效的肽在小鼠腹膜大肠杆菌感染模型中显示出治疗效果。本研究介绍了一种发现amp的有效策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature Biomedical Engineering
Nature Biomedical Engineering Medicine-Medicine (miscellaneous)
CiteScore
45.30
自引率
1.10%
发文量
138
期刊介绍: Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书